Skip to content
10-Q

Quarterly Report

MARIMED INC. MRMD

0001522767-25-000052

← back to feed
Filed
May 8, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 7, 2025 389.23M sh
Long Term Debt Q1 2025 · Mar 31, 2025 $77.37M
Cash And Equivalents Q1 2025 · Mar 31, 2025 $7.2M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $7.28M
Current Liabilities Q1 2025 · Mar 31, 2025 $55.31M
Current Liabilities Q1 2025 · Dec 31, 2024 $48.68M
Total Liabilities Q1 2025 · Mar 31, 2025 $134.06M
Total Liabilities Q1 2025 · Dec 31, 2024 $128.11M
Current Assets Q1 2025 · Mar 31, 2025 $58M
Current Assets Q1 2025 · Dec 31, 2024 $53.51M
Total Assets Q1 2025 · Mar 31, 2025 $208M
Total Assets Q1 2025 · Dec 31, 2024 $206.99M
Shares Diluted Q1 2025 · Mar 31, 2024 375.21M sh
Capex Q1 2025 · Mar 31, 2024 $3.37M
Operating Cash Flow Q1 2025 · Mar 31, 2024 $3.21M
Eps Diluted Q1 2025 · Mar 31, 2024 $0.00
Eps Basic Q1 2025 · Mar 31, 2024 $0.00
Net Income Q1 2025 · Mar 31, 2024 −$1.3M
Operating Income Q1 2025 · Mar 31, 2024 $2.02M
Gross Profit Q1 2025 · Mar 31, 2024 $16.47M
Cost Of Revenue Q1 2025 · Mar 31, 2024 $21.46M
Revenue Q1 2025 · Mar 31, 2024 $37.93M